Glaucoma Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

According to the latest report by IMARC Group, titled “Glaucoma Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the global glaucoma therapeutics market grew at a CAGR of around 4% during 2014-2019. Glaucoma therapeutics refer to the treatment alternatives specified for primary open-angle (POA) and primary angle-closure (PAC) glaucoma. Glaucoma is identified by structural changes in the optic nerves causing visual loss and blindness. Its treatment primarily involves applying topical eye drops that usually consist of beta-blockers, prostaglandin analogs, cholinergic, etc. These eye drops decrease fluid formation in the eyes, thereby reducing the intraocular pressure (IOP). In line with this, the treatment is followed by traditional or laser surgical procedures or both, which use implantable extended-release devices, polymer-based contact lenses, etc.

Request Free Sample Report: https://www.imarcgroup.com/glaucoma-therapeutics-market/requestsample

The growing prevalence of glaucoma, especially among patients suffering from diabetes, is one of the primary factors propelling the market growth. Additionally, the rising geriatric population who are more susceptible to numerous eye disorders, such as age-related macular degeneration (AMD), cataract, dry eye, etc., is also driving the demand for glaucoma therapeutics. Furthermore, the increasing penetration of advanced glaucoma diagnostic methods, along with several upgradations in the healthcare infrastructures, are further expected to catalyze the market growth. Looking forward, IMARC Group expects the global glaucoma therapeutics market to continue its moderate growth during the next five years.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global glaucoma therapeutics market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region, drug class, indication and end user.

Breakup by Drug Class:
• Prostaglandin Analogs
• Beta Blockers
• Alpha Adrenergic Agonists
• Carbonic Anhydrase Inhibitors
• Combination Drugs
• Others

Breakup by Indication:
• Open Angle Glaucoma
• Angle Closure Glaucoma
• Others

Breakup by End User:
• Hospitals
• Ophthalmic Clinics
• Ambulatory Surgery Centers
• Others

Breakup by Region:
• North America
o United States
o Canada
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Others
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Others
• Latin America
o Brazil
o Mexico
o Others
• Middle East and Africa

Competitive Landscape Key Player:
• Aerie Pharmaceuticals Inc.
• Allergan Plc
• Bausch & Lomb Incorporated (Bausch Health Companies Inc.)
• Inotek Pharmaceuticals Corp.
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• Santen Pharmaceutical Co. Ltd.
• SIFI S.p.A
• Teva Pharmaceutical Industries Ltd.

Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/glaucoma-therapeutics-market

Other Reports BY IMARC Group:

Pay Tv Market: https://www.imarcgroup.com/pay-tv-market

Material Testing Market: https://www.imarcgroup.com/material-testing-market

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800 |
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

This release was published on openPR.